Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions
The MMA Academy is developing a new course in advanced regulatory sciences for medicinal products — and this week is dedicated to listening to you. Take a moment to share your views and help shape a programme that reflects real training needs. Complete this ?? Form and tell us what matters most to you. #DesignedWithTheRegulatoryCommunity